---
figid: PMC6178121__10.1177_1179573518803585-fig2
figlink: /pmc/articles/PMC6178121/figure/fig2-1179573518803585/
number: F2
caption: Pathway analysis shows apolipoprotein E along with its respective interactions
  in Parkinson’s disease and schizophrenia pathway. Apolipoprotein E is shown in white
  node, its interacting nodes in Parkinson’s disease pathway are highlighted in green,
  interacting nodes in schizophrenia pathway are highlighted in pink, and nodes that
  are common to both the pathways are in blue colour. First node interactions are
  shown circled by bold lines; and interactions from there on are shown circled by
  normal lines. Interactions that are connecting the nodes are shown by grey lines.
pmcid: PMC6178121
papertitle: 'Evaluation of Serum Apolipoprotein E as a Potential Biomarker for Pharmacological
  Therapeutic Efficacy Monitoring in Dopamine Dictated Disease Spectrum of Schizophrenia
  and Parkinson’s disease: A Preliminary Study.'
reftext: Ashish Kumar Gupta, et al. J Cent Nerv Syst Dis. 2018;10:1179573518803585.
pmc_ranked_result_index: '28537'
pathway_score: 0.668828
filename: 10.1177_1179573518803585-fig2.jpg
figtitle: Pathway analysis shows apolipoprotein E along with its respective interactions
  in Parkinson’s disease and schizophrenia pathway
year: '2018'
organisms: Homo sapiens
ndex: ab4d3a41-df34-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6178121__10.1177_1179573518803585-fig2.html
  '@type': Dataset
  description: Pathway analysis shows apolipoprotein E along with its respective interactions
    in Parkinson’s disease and schizophrenia pathway. Apolipoprotein E is shown in
    white node, its interacting nodes in Parkinson’s disease pathway are highlighted
    in green, interacting nodes in schizophrenia pathway are highlighted in pink,
    and nodes that are common to both the pathways are in blue colour. First node
    interactions are shown circled by bold lines; and interactions from there on are
    shown circled by normal lines. Interactions that are connecting the nodes are
    shown by grey lines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CYC1
  - APOE
  - ACTG1
  - GPR162
  - A2M
  - DCTN1
  - FLNA
  - CASP3
  - ATP5MPL
  - BCL2
  - CASP1
  - AMPD1
  - MYO1A
  - APOA4
  - C3
  - APOA1
  - APOA2
  - SNCA
  - APOA5
  - SRPK2
  - VLDLR
  - LRP8
  - ATP5F1E
  - ATP5IF1
  - LRP2
  - PPIF
  - PSEN1
  - NEFM
  - PRKN
  - MT-ATP8
  - ATP4B
  - APP
  - MT-ATP6
  - SLC1A1
  - SLC25A6
  - LDLR
  - LRP1
  - GIPC1
  - PTEN
  - SMAD2
  - ATP
  - amino
  - berinethreonine
  - NADHubiquinone
  - AMP
  - APOC4
  - ADP
  - MAPT
  - Parkinson's Disease
  - Schizophrenia
  - Breast cancer
  - Complement-C3
genes:
- word: (CYC1)
  symbol: CYC1
  source: hgnc_symbol
  hgnc_symbol: CYC1
  entrez: '1537'
- word: (APOE)
  symbol: APOE
  source: hgnc_symbol
  hgnc_symbol: APOE
  entrez: '348'
- word: (ACTG1)
  symbol: ACTG1
  source: hgnc_symbol
  hgnc_symbol: ACTG1
  entrez: '71'
- word: alpha-2
  symbol: A-2
  source: hgnc_alias_symbol
  hgnc_symbol: GPR162
  entrez: '27239'
- word: (A2M)
  symbol: A2M
  source: hgnc_symbol
  hgnc_symbol: A2M
  entrez: '2'
- word: (DCTN1)
  symbol: DCTN1
  source: hgnc_symbol
  hgnc_symbol: DCTN1
  entrez: '1639'
- word: (FLNA)
  symbol: FLNA
  source: hgnc_symbol
  hgnc_symbol: FLNA
  entrez: '2316'
- word: Apolipoprotein
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOE
  entrez: '348'
- word: (CASP3)
  symbol: CASP3
  source: hgnc_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP5MPL
  entrez: '9556'
- word: (BCL2)
  symbol: BCL2
  source: hgnc_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: (CASP1)
  symbol: CASP1
  source: hgnc_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: MAD
  symbol: MAD
  source: hgnc_alias_symbol
  hgnc_symbol: AMPD1
  entrez: '270'
- word: (MYO1A)
  symbol: MYO1A
  source: hgnc_symbol
  hgnc_symbol: MYO1A
  entrez: '4640'
- word: Apolipoprotein
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA4
  entrez: '337'
- word: (C3)
  symbol: C3
  source: hgnc_symbol
  hgnc_symbol: C3
  entrez: '718'
- word: Apolipoprotein
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA1
  entrez: '335'
- word: Apolipoprotein
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA2
  entrez: '336'
- word: (SNCA)
  symbol: SNCA
  source: hgnc_symbol
  hgnc_symbol: SNCA
  entrez: '6622'
- word: Apolipoprotein
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA5
  entrez: '116519'
- word: (SRPK2)
  symbol: SRPK2
  source: hgnc_symbol
  hgnc_symbol: SRPK2
  entrez: '6733'
- word: (VLDLR)
  symbol: VLDLR
  source: hgnc_symbol
  hgnc_symbol: VLDLR
  entrez: '7436'
- word: (LRP8)
  symbol: LRP8
  source: hgnc_symbol
  hgnc_symbol: LRP8
  entrez: '7804'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP5F1E
  entrez: '514'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP5IF1
  entrez: '93974'
- word: (LRP2)
  symbol: LRP2
  source: hgnc_symbol
  hgnc_symbol: LRP2
  entrez: '4036'
- word: (PPIF)
  symbol: PPIF
  source: hgnc_symbol
  hgnc_symbol: PPIF
  entrez: '10105'
- word: (PSEN1)
  symbol: PSEN1
  source: hgnc_symbol
  hgnc_symbol: PSEN1
  entrez: '5663'
- word: (NEFM)
  symbol: NEFM
  source: hgnc_symbol
  hgnc_symbol: NEFM
  entrez: '4741'
- word: (PARK2)
  symbol: PARK2
  source: hgnc_prev_symbol
  hgnc_symbol: PRKN
  entrez: '5071'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: MT-ATP8
  entrez: '4509'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP4B
  entrez: '496'
- word: (APP)
  symbol: APP
  source: hgnc_symbol
  hgnc_symbol: APP
  entrez: '351'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: MT-ATP6
  entrez: '4508'
- word: (SLC1A1)
  symbol: SLC1A1
  source: hgnc_symbol
  hgnc_symbol: SLC1A1
  entrez: '6505'
- word: (SLC25A6)
  symbol: SLC25A6
  source: hgnc_symbol
  hgnc_symbol: SLC25A6
  entrez: '293'
- word: (LDLR)
  symbol: LDLR
  source: hgnc_symbol
  hgnc_symbol: LDLR
  entrez: '3949'
- word: (LRP1)
  symbol: LRP1
  source: hgnc_symbol
  hgnc_symbol: LRP1
  entrez: '4035'
- word: (GIPC1)
  symbol: GIPC1
  source: hgnc_symbol
  hgnc_symbol: GIPC1
  entrez: '10755'
- word: (PTEN)
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: (SMAD2)
  symbol: SMAD2
  source: hgnc_symbol
  hgnc_symbol: SMAD2
  entrez: '4087'
chemicals:
- word: ATP
  source: MESH
  identifier: D000255
- word: amino
  source: MESH
  identifier: D000596
- word: berinethreonine
  source: ''
  identifier: ''
- word: NADHubiquinone
  source: ''
  identifier: ''
- word: AMP
  source: MESH
  identifier: D000249
- word: APOC4
  source: MESH
  identifier: C110229
- word: ADP
  source: MESH
  identifier: D000244
- word: MAPT
  source: MESH
  identifier: C036122
diseases:
- word: Parkinson's Disease
  source: MESH
  identifier: D010300
- word: Schizophrenia
  source: MESH
  identifier: D012559
- word: Breast cancer
  source: MESH
  identifier: D001943
- word: Complement-C3
  source: MESH
  identifier: C565169
figid_alias: PMC6178121__F2
redirect_from: /figures/PMC6178121__F2
figtype: Figure
---
